Clinical Trial Update: Quality of Life Study of Helixate NexGen

View source ↗

Summary

A quality-of-life study of Helixate NexGen for Hemophilia A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Helixate NexGen (Factor VIII, recombinant)

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia A | Status: COMPLETED